Ufp Technologies (UFPT) Share-based Compensation (2010 - 2026)
Ufp Technologies (UFPT) posted Share-based Compensation of $2.7 million for Q1 2026, up 1246.31% on a QoQ basis from $203000.0 in Q4 2025, and down 30.17% year-over-year from $3.9 million in Q1 2025.
Ufp Technologies (UFPT) Share-based Compensation (2010 - 2026) Analysis & Trends
Ufp Technologies' Share-based Compensation history runs 17 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- Quarterly Share-based Compensation fell 30.17% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 67.52% YoY) and the FY2025 annual result came in at $4.1 million, down 39.83% from the prior year.
- Share-based Compensation was $2.7 million for Q1 2026 at Ufp Technologies, up from $203000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.7 million in Q3 2024 and bottomed at -$3000.0 in Q2 2022.
- A 5-year average of $1.7 million and a median of $1.4 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation plunged 100.48% — and 2023, when it surged 22766.67%.
- Ufp Technologies' Share-based Compensation stood at $1.9 million in 2022, then slumped by 37.51% to $1.2 million in 2023, then surged by 72.54% to $2.1 million in 2024, then slumped by 90.12% to $203000.0 in 2025, then soared by 1246.31% to $2.7 million in 2026.
- Business Quant data shows UFPT's Share-based Compensation at $2.7 million in Q1 2026, $203000.0 in Q4 2025, and $58000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 2.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.73 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | 203,000.00 |
| Dec 31, 2025 | 203,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 3.91 Mn |
| Mar 31, 2025 | 3.91 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 6.70 Mn |
| Sep 30, 2024 | 6.70 Mn |
| Jun 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |